CD19 and acute lymphoblastic leukemia: According to immuno-phenotyping findings, common Pre-B ALL was diagnosed in 75% of study’s cases from ALL group who expressed CD19, cytoplasmic- CD22 (cCD22) and CD79a (cCD79a) markers.